drugset
Drugs / COVIGEN C19
last change Jul 2023 re-read 3 minutes ago

COVIGEN C19

Vaccine

Developed for
COVID-19
Investigated by
Bionet Co., Ltd · Institute for Clinical Pathology and Medical Research · Technovalia · Telethon Kids Institute · University of Sydney

Trials 1

today NCT04742842 · Ph 1
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04742842 Jun 2021 → Jul 2022 COVID-19 University of Sydney Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as COVIGEN C19 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04742842 ↗
Modality Vaccine “new investigational DNA vaccine” NCT04742842 ↗